Showcase Your Capabilities for Spatial Biology to Drug Development Leaders In-Person

The Spatial Biology for Immuno-Oncology Summit is the definitive platform to attract the attention of immuno-oncology’s top decision-makers in pharma.

With the increased momentum for spatial biology after being named “Method of the Year” in 2021 by Nature Methods, and already contributing to multiple novel insights in immuno-oncology, the race to becoming market leaders is fiercer than ever.

As the field continues to rapidly evolve, the need to identify & meet cutting-edge service providers is business critical

Email to learn more.

Industry research with the Spatial Biology for Immuno-Oncology Summit has highlighted the need for capabilities in:

AI-powered Pathology

Imaging Companies

Spatial Profiling

Biomarker Platforms

Data Analysis

Assay Development